105 related articles for article (PubMed ID: 38963028)
1. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).
Luo Y; Zhang W; Qin G
Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 38963028
[TBL] [Abstract][Full Text] [Related]
2. New insights into the use of biomarkers of diabetic nephropathy.
Jha JC; Jandeleit-Dahm KA; Cooper ME
Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
[TBL] [Abstract][Full Text] [Related]
3. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients.
Darmayanti S; Lesmana R; Meiliana A; Abdulah R
Curr Diabetes Rev; 2021; 17(6):e123120189796. PubMed ID: 33393899
[TBL] [Abstract][Full Text] [Related]
4. Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.
Campion CG; Sanchez-Ferras O; Batchu SN
Can J Kidney Health Dis; 2017; 4():2054358117705371. PubMed ID: 28616250
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy.
Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J
Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies.
Roointan A; Gheisari Y; Hudkins KL; Gholaminejad A
Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2253-2272. PubMed ID: 34059383
[TBL] [Abstract][Full Text] [Related]
7. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.
Thipsawat S
Diab Vasc Dis Res; 2021; 18(6):14791641211058856. PubMed ID: 34791910
[TBL] [Abstract][Full Text] [Related]
8. Potential Plasma Metabolite Biomarkers of Diabetic Nephropathy: Untargeted Metabolomics Study.
Trifonova OP; Maslov DL; Balashova EE; Lichtenberg S; Lokhov PG
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36422065
[TBL] [Abstract][Full Text] [Related]
9. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease.
Pereira PR; Carrageta DF; Oliveira PF; Rodrigues A; Alves MG; Monteiro MP
Med Res Rev; 2022 Jul; 42(4):1518-1544. PubMed ID: 35274315
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of diabetic nephropathy, the present and the future.
Jim B; Santos J; Spath F; Cijiang He J
Curr Diabetes Rev; 2012 Sep; 8(5):317-28. PubMed ID: 22698077
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators.
Cordero-Pérez P; Sánchez-Martínez C; García-Hernández PA; Saucedo AL
Nefrologia (Engl Ed); 2020; 40(6):585-596. PubMed ID: 33036786
[TBL] [Abstract][Full Text] [Related]
13. Advancements, Challenges, and clinical implications of integration of metabolomics technologies in diabetic nephropathy.
Sharma V; Khokhar M; Panigrahi P; Gadwal A; Setia P; Purohit P
Clin Chim Acta; 2024 Jul; 561():119842. PubMed ID: 38969086
[TBL] [Abstract][Full Text] [Related]
14. Glomerular podocytes in diabetic renal disease.
Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
[TBL] [Abstract][Full Text] [Related]
15. Study of diabetic nephropathy in the proteomic era.
Thongboonkerd V
Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
[TBL] [Abstract][Full Text] [Related]
16. Predictive metabolic signatures for the occurrence and development of diabetic nephropathy and the intervention of Ginkgo biloba leaves extract based on gas or liquid chromatography with mass spectrometry.
Du Y; Xu BJ; Deng X; Wu XW; Li YJ; Wang SR; Wang YN; Ji S; Guo MZ; Yang DZ; Tang DQ
J Pharm Biomed Anal; 2019 Mar; 166():30-39. PubMed ID: 30599279
[TBL] [Abstract][Full Text] [Related]
17. Diabetic nephropathy: traditional to proteomic markers.
Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
[TBL] [Abstract][Full Text] [Related]
18. Review of early circulating biomolecules associated with diabetes nephropathy - Ideal candidates for early biomarker array test for DN.
Quan KY; Yap CG; Jahan NK; Pillai N
Diabetes Res Clin Pract; 2021 Dec; 182():109122. PubMed ID: 34742785
[TBL] [Abstract][Full Text] [Related]
19. Relationship of Soluble Klotho and Early Stage of Diabetic Nephropathy: A Systematic Review and Meta-Analysis.
Xin C; Sun X; Li Z; Gao T
Front Endocrinol (Lausanne); 2022; 13():902765. PubMed ID: 35692408
[TBL] [Abstract][Full Text] [Related]
20. Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice.
Wei T; Zhao L; Jia J; Xia H; Du Y; Lin Q; Lin X; Ye X; Yan Z; Gao H
Sci Rep; 2015 Jul; 5():11998. PubMed ID: 26149603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
